Guess Who Picked Audentes Therapeutics Inc. (NASDAQ:BOLD) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Audentes Therapeutics Inc. (NASDAQ:BOLD) reported that Flynn James E has picked up 1,214,423 of common stock as of 2017-04-26.
The acquisition brings the aggregate amount owned by Flynn James E to a total of 1,214,423 representing less than 4.38% stake in the company.
For those not familiar with the company, Audentes Therapeutics, Inc. is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects. The Company has a portfolio of product candidates, including AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM); AT342 for the treatment of Crigler-Najjar Syndrome (Crigler-Najjar); AT982 for the treatment of Pompe disease, and AT307 for the treatment of the CASQ2 subtype of Catecholaminergic Polymorphic Ventricular Tachycardia (CASQ2-CPVT). The Company’s subsidiary is Audentes Therapeutics UK Ltd. As of September 30, 2016, the Company had not generated any revenues.
A glance at Audentes Therapeutics Inc. (NASDAQ:BOLD)’s key stats reveals a current market capitalization of 409.36 Million based on 26.93 Million shares outstanding and a price at last close of $14.98 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-07-25, Woiwode picked up 219 at a purchase price of $15.00. This brings their total holding to 11,308 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Audentes Therapeutics Inc. (NASDAQ:BOLD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Picked Professional Diversity Network Inc. (NASDAQ:IPDN) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Professional Diversity Network Inc. (NASDAQ:IPDN) reported that Alomari Ahmed has picked up 245,000 of common stock as of 2017-04-26.
The acquisition brings the aggregate amount owned by Alomari Ahmed to a total of 245,000 representing less than 6.2% stake in the company.
For those not familiar with the company, Professional Diversity Network, Inc. is an operator of professional networks with a focus on diversity. The Company serves various communities, including Women, Hispanic-Americans, African-Americans, Asian-Americans, Disabled, Military Professionals, and Lesbian, Gay, Bisexual and Transgender (LGBT). The Company’s segments include Professional Diversity Network (PDN Network), which includes online professional networking communities with career resources for the needs of various diverse cultural groups; National Association of Professional Women (NAPW Network), a women-only professional networking organization, and Noble Voice operations (Noble Voice), a career consultation and lead generation service. The Noble Voice call centers qualify callers for real-time job placement. The PDN Network consists of various online professional networking communities dedicated to serving diverse professionals in the United States and employers seeking to hire diverse talent.
A glance at Professional Diversity Network Inc. (NASDAQ:IPDN)’s key stats reveals a current market capitalization of 36.35 Million based on 3.93 Million shares outstanding and a price at last close of $9.40 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-01-18, Cosmic picked up 312,500 at a purchase price of $9.60. This brings their total holding to 2,295,842 as of the date of the filing.
On the sell side, the most recent transaction saw Proman unload 3,274 shares at a sale price of 0.63. This brings their total holding to 1,647,397.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Professional Diversity Network Inc. (NASDAQ:IPDN) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
GAMCO Investors is Buying Mocon Inc. (NASDAQ:MOCO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Mocon Inc. (NASDAQ:MOCO) reported that GAMCO Investors has picked up 272,150 of common stock as of 2017-04-25.
The acquisition brings the aggregate amount owned by GAMCO Investors to a total of 272,150 representing less than 4.65% stake in the company.
For those not familiar with the company, MOCON, Inc. designs, manufactures, markets and services products, and provides consulting services, primarily in the test and measurement, analytical instrument and services markets. The Company’s segments are Permeation Products and Services (Permeation), Package Testing Products and Services (Package Testing), and Industrial Analyzer Products and Services and Other (Industrial Analyzers and Other). Its products include instruments that detect, measure and monitor gases and other chemical compounds. The Permeation segment includes instruments and services that measure the rate at which various gases and vapors permeate through a range of materials. The Package Testing segment manufactures and sells approximately three primary products, such as headspace analyzers, leak detection equipment and gas mixers. The Industrial Analyzers and Other segment manufactures and sells approximately two types of gas analyzer instruments, including gas chromatographs and total hydrocarbon analyzers.
A glance at Mocon Inc. (NASDAQ:MOCO)’s key stats reveals a current market capitalization of 175.43 Million based on 5.87 Million shares outstanding and a price at last close of $29.85 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-06-10, Goskowicz picked up 245 at a purchase price of $14.38. This brings their total holding to 1,000 as of the date of the filing.
On the sell side, the most recent transaction saw Demorest unload 2,000 shares at a sale price of $16.60. This brings their total holding to 209,175.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Mocon Inc. (NASDAQ:MOCO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Man Group Plc. is Buying Tangoe Inc. (OTCMKTS:TNGO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Tangoe Inc. (OTCMKTS:TNGO) reported that Man Group Plc has picked up 1,993,543 of common stock as of 2017-04-25.
The acquisition brings the aggregate amount owned by Man Group Plc to a total of 1,993,543 representing less than 5.06% stake in the company.
For those not familiar with the company, Tangoe, Inc. is a provider of information technology (IT) and Telecom Expense Management (TEM) software and related services. The Company offers its services to a range of global enterprises and service providers. Its products and solutions include mobility, telecom, cloud, IT expense, strategic consulting and mobility as a service (MaaS). Its mobility solution includes expense management; procurement, logistics and activation; usage management; enterprise mobility; mobile support, and financial management. Its IT expense solution includes expense management, inventory and asset management, usage management and financial management. Its enterprise mobility and IT consulting services include strategic sourcing; strategy assessment, planning, and policy development, and implementation and transition support. The Company offers contract sourcing, strategy and policy consulting, service maturity assessment, global services benchmarking and lifecycle advisory, among others.
A glance at Tangoe Inc. (OTCMKTS:TNGO)’s key stats reveals a current market capitalization of 214.90 Million based on 39.43 Million shares outstanding and a price at last close of $5.45 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-04-13, Clearlake picked up 1,202,666 at a purchase price of $7.25. This brings their total holding to 7,492,797 as of the date of the filing.
On the sell side, the most recent transaction saw Clearlake unload 1,590,000 shares at a sale price of $8.00. This brings their total holding to 5,902,797.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Tangoe Inc. (OTCMKTS:TNGO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Alden Global Capital Picked Up Freds Inc. (NASDAQ:FRED) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Freds Inc. (NASDAQ:FRED) reported that Alden Global Capital has picked up 9,275,000 of common stock as of 2017-04-25.
The acquisition brings the aggregate amount owned by Alden Global Capital to a total of 9,275,000 representing less than 24.4% stake in the company.
For those not familiar with the company, Fred’s, Inc. (Fred’s) is engaged in the sale of general merchandise through its retail discount stores and full service pharmacies. The Company sells general merchandise to its over 20 franchisees. The Company has approximately 660 retail stores, over 370 pharmacies, and approximately three specialty pharmacy facilities located in over 15 states mainly in the Southeastern United States. The Company is licensed to dispense pharmaceuticals in approximately 50 states. The Company operates approximately 640 company-owned stores, including over 60 express stores (or Xpress stores). Fred’s is a combination of pharmacy, dollar store and mass merchant strategically located in smaller markets. It offers various product categories, including consumables, such as tobacco, food and beverage, prescription pharmaceuticals, paper and cleaning supplies, pet supplies, health and beauty aids, and discretionary products, such as home decor, seasonal merchandise, auto and hardware, and lawn and garden.
A glance at Freds Inc. (NASDAQ:FRED)’s key stats reveals a current market capitalization of 572.43 Million based on 37.99 Million shares outstanding and a price at last close of $14.47 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-22, Alden picked up 1,800,000 at a purchase price of $19.36. This brings their total holding to 9,275,000 as of the date of the filing.
On the sell side, the most recent transaction saw Hayes unload 10,000 shares at a sale price of 20.17. This brings their total holding to 1,524,909.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Freds Inc. (NASDAQ:FRED) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Searchlight Minerals Corp. (OTCMKTS:SRCH) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Searchlight Minerals Corp. (OTCMKTS:SRCH) reported that Luxor Capital Group has picked up 93,930,386 of common stock as of 2017-04-25.
The acquisition brings the aggregate amount owned by Luxor Capital Group to a total of 93,930,386 representing less than 26.1% stake in the company.
For those not familiar with the company, Searchlight Minerals Corp. is an exploration-stage company. The Company is engaged in a slag reprocessing project, the Clarkdale Slag Project. The Clarkdale Slag Project, located in Clarkdale, Arizona, is a reclamation project to recover precious and base metals from the reprocessing of slag produced from the smelting of copper ore mined at the United Verde Copper Mine in Jerome, Arizona. There is approximately 20 million tons of slag available to be processed at the Clarkdale site. The Company’s processing flow diagram consists of grinding the slag material using high pressure grinding rolls (HPGR), then pretreatment by melting the slag at high temperature, followed by leaching the slag in an autoclave. The Clarkdale Slag Project is located in Clarkdale, Arizona, approximately 107 miles north of Phoenix, Arizona and over 50 miles southwest of Flagstaff, Arizona in Yavapai County. The slag pile occupies approximately 45 acres on the property.
A glance at Searchlight Minerals Corp. (OTCMKTS:SRCH)’s key stats reveals a current market capitalization of 17.31 Million based on 345.60 Million shares outstanding and a price at last close of $0.05 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-18, Luxor picked up 31,712,229 at a purchase price of $0.04. This brings their total holding to 37,179,695 as of the date of the filing.
On the sell side, the most recent transaction saw Ager unload 5,900 shares at a sale price of 0.64. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Searchlight Minerals Corp. (OTCMKTS:SRCH) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Picked Edge Therapeutics Inc. (NASDAQ:EDGE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Edge Therapeutics Inc. (NASDAQ:EDGE) reported that Satter Muneer A. has picked up 1,800,000 of common stock as of 2017-04-25.
The acquisition brings the aggregate amount owned by Satter Muneer A. to a total of 1,800,000 representing less than 5.8% stake in the company.
For those not familiar with the company, Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening critical care conditions. The Company’s initial product candidates target rare, acute, life-threatening neurological and other conditions. The Company’s product candidates utilize its programmable, biodegradable polymer-based development platform (the Precisa Platform), a delivery mechanism that seeks to enable targeted and sustained drug exposure and avoid the dose-limiting side effects associated with the current standards of care. The Company’s product candidates include EG-1962 and EG-1964. EG-1962 is a polymer-based microsphere containing nimodipine suspended in a diluent of sodium hyaluronate was developed using its Precisa development platform to improve patient outcomes following aneurysmal subarachnoid hemorrhage (aSAH).
A glance at Edge Therapeutics Inc. (NASDAQ:EDGE)’s key stats reveals a current market capitalization of 341.17 Million based on 30.81 Million shares outstanding and a price at last close of $10.35 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-06, Loughlin picked up 3,000 at a purchase price of $9.24. This brings their total holding to 6,000 as of the date of the filing.
On the sell side, the most recent transaction saw Leuthner unload 1,500 shares at a sale price of 9.52. This brings their total holding to 245,479.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Edge Therapeutics Inc. (NASDAQ:EDGE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
See Who Picked Tocagen Inc. (NASDAQ:TOCA) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Tocagen Inc. (NASDAQ:TOCA) reported that Foresite Capital Fund Iii, L.p. has picked up 915,000 of common stock as of 2017-04-25.
The acquisition brings the aggregate amount owned by Foresite Capital Fund Iii, L.p. to a total of 915,000 representing less than 4.6% stake in the company.
For those not familiar with the company, Tocagen Inc., (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the deoxyribonucleic acid (DNA) of cancer cells. Its lead product candidates are vocimagene amiretrorepvec (Toca 511) and flucytosine extended release (Toca FC). Toca 511 is an investigational injectable retroviral replicating vector (RRV) that encodes a prodrug activator enzyme, cytosine deaminase (CD). Toca FC is an investigational extended-release version of 5-fluorocytosine (5-FC), a prodrug that is inactive as an anti-cancer drug. As of February, 2017, Tocagen has completed enrollment of the Phase II portion with 187 patients.
A glance at Tocagen Inc. (NASDAQ:TOCA)’s key stats reveals a current market capitalization of 238.70 Million based on 18.50 Million shares outstanding and a price at last close of $13.40 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-04-19 Das picked up 2,500 at a purchase price of $10.00. This brings their total holding to 2,500 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Tocagen Inc. (NASDAQ:TOCA) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.